Designing carbonic anhydrase inhibitors for the treatment of breast cancer

Bibliography

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumors as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767-77
   PubMed Web of Science ®Google Scholar
• McDonald PC, Winum JY, Supuran CT, et al. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 2012;3:84-97
   PubMed Web of Science ®Google Scholar
• Wilex AG announces results of phase III ARISER study with RENCAREX® in clear cell renal cell carcinoma. Available from: http://www.wilex.de/portfolio-english/rencarex/overview-rencarex/
   Google Scholar
• Teicher BA, Liu SD, Liu JT, et al. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. AntiCancer Res 1993;13:1549-56
   PubMed Web of Science ®Google Scholar
• Chegwidden WR, Spencer IM. Sulphonamide inhibitors of carbonic anhydrase inhibit the growth of human lymphoma cells in culture. Inflammopharmacology 1995;3:231-9
   Google Scholar
• Supuran CT, Briganti F, Tilli S, et al. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? Bioorg Med Chem 2001;9:703-14
   PubMed Web of Science ®Google Scholar
• Poulsen SA. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009. Expert Opin Ther Pat 2010;20:795-806
   PubMed Web of Science ®Google Scholar
• Monti SM, Supuran CT, De Simone G. Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013). Expert Opin Ther Pat 2013;23:737-49
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421-68
   PubMed Web of Science ®Google Scholar
• Winum JY, Rami M, Scozzafava A, et al. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445-63
   PubMed Web of Science ®Google Scholar
• Winum JY, Colinas PA, Supuran CT. Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer. Bioorg Med Chem 2013;21:1419-26
   PubMed Web of Science ®Google Scholar
• Winum JY, Supuran CT. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2015;30(2):321-4
   PubMed Web of Science ®Google Scholar
• Rami M, Dubois L, Parvathaneni NK, et al. Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates. J Med Chem 2013;56:8512-20
   PubMed Web of Science ®Google Scholar
• Dubois L, Peeters SG, van Kuijk SJ, et al. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother Oncol 2013;108:523-8
   PubMed Web of Science ®Google Scholar
• Ward C, Langdon SP, Mullen P, et al. New strategies for targeting the hypoxic tumor microenvironment in breast cancer. Cancer Treat Rev 2013;39:171-9
   PubMed Web of Science ®Google Scholar
• Swietach P, Wigfield S, Cobden P, et al. Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growth. J Biol Chem 2008;283:20473-83
   PubMed Web of Science ®Google Scholar
• Swietach P, Patiar S, Supuran CT, et al. The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in 3-D tumor-cell growths. J Biol Chem 2009;284:20299-310
   PubMed Web of Science ®Google Scholar
• Supuran CT. New drugs interfering with pH regulation in hypoxic tumors. In: Pastorekova S, Kopacek J, editors. Tumor hypoxia: molecular mechanisms and clinical implications. VEDA, SAS Publishing House/Peter Lang; Bratislava: 2012. p. 517-42
   Google Scholar
• Pastorekova S, Supuran CT. Carbonic anhydrase IX: from biology to therapy. In: Melillo G, editor. Hypoxia and cancer – biological implications and therapeutic opportunities. Humana Press, Springer; New York, Heidelberg, Dordrecht, London: 2014. p. 121-53
   Google Scholar
• Supuran CT, Capasso C, De Simone G. Carbonic Anhydrase II as target from drug design. In: Supuran CT, De Simone G, editors. The carbonic anhydrases as biocatalysts. Elsevier; Amsterdam: 2015. p. 51-90
   Google Scholar
• Gatenby RA, Gillies RJ. A microenvironmental model of carginogenesis. Nat Rev Cancer 2008;8:56-61
   PubMed Web of Science ®Google Scholar
• Ebbesen P, Pettersen EO, Gorr TA, et al. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. J Enzyme Inhib Med Chem 2009;24(S1):1-39
   PubMed Web of Science ®Google Scholar
• Bartosova M, Parkkila S, Pohlodek K, et al. Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. J Pathol 2002;197:314-21
   PubMed Web of Science ®Google Scholar
• Kyndi M, Sorensen FB, Knudsen H, et al. Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials. Breast Cancer Res 2008;10:R24
   PubMed Web of Science ®Google Scholar
• Tan EY, Yan M, Campo L, et al. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumors and is associated with resistance to chemotherapy. Br J Cancer 2009;100:405-11
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors–Part 94. 1,3,4-thiadiazole-2-sulfonamidederivatives as antitumor agents? Eur J Med Chem 2000;35:867-74
   PubMed Web of Science ®Google Scholar
• Pacchiano F, Carta F, McDonald PC, et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 2011;54:1896-902
   PubMed Web of Science ®Google Scholar
• Supuran C, Dedhar S, Mcdonald PC, Carta F. Novel sulfonamide compounds for inhibition of metastatic tumor growth. WO021963; 2012
   Google Scholar
• Colinas PA. Novel sulfonamide compounds for inhibition of metastatic tumor growth (WO2012021963). Expert Opin Ther Pat 2013.23:761-3
   Google Scholar
• Lou Y, McDonald PC, Oloumi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011;71:3364-76
   PubMed Web of Science ®Google Scholar
• Lock FE, McDonald PC, Lou Y, et al. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene 2013;32:5210-19
   PubMed Web of Science ®Google Scholar
• Available from: https://clinicaltrials.gov/ct2/show/NCT02215850
   Google Scholar
• Winum JY, Carta F, Ward C, et al. Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines. Bioorg Med Chem Lett 2012;22:4681-5
   PubMed Web of Science ®Google Scholar
• Gieling RG, Babur M, Mamnani L, et al. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J Med Chem 2012;55:5591-600
   PubMed Web of Science ®Google Scholar
• Touisni N, Maresca A, McDonald PC, et al. Glycosylcoumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 2011;54:8271-7
   PubMed Web of Science ®Google Scholar
• Supuran C, Dedhar S, Winum JY, et al. Carbonic anhydrase inhibitors with antimetastatic activity. WO070024; 2012
   Google Scholar
• Carradori S. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024. Expert Opin Ther Pat 2013;23:751-6
   PubMed Web of Science ®Google Scholar
• Gieling RG, Parker CA, De Costa LA, et al. Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro. J Enzyme Inhib Med Chem 2013;28:360-9
   PubMed Web of Science ®Google Scholar